Paralel Advisors LLC Buys Shares of 66,500 Omega Healthcare Investors, Inc. $OHI

Paralel Advisors LLC purchased a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 66,500 shares of the real estate investment trust’s stock, valued at approximately $3,171,000.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth about $1,838,155,000. Bank of New York Mellon Corp acquired a new position in Omega Healthcare Investors during the 2nd quarter valued at about $275,230,000. Norges Bank acquired a new position in Omega Healthcare Investors during the 4th quarter valued at about $156,166,000. Invesco Ltd. grew its position in Omega Healthcare Investors by 101.7% in the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock worth $208,775,000 after purchasing an additional 2,493,877 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Omega Healthcare Investors in the 4th quarter worth about $93,476,000. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 0.2%

Omega Healthcare Investors stock opened at $46.81 on Friday. Omega Healthcare Investors, Inc. has a 52 week low of $39.26 and a 52 week high of $52.39. The stock has a market cap of $14.18 billion, a price-to-earnings ratio of 16.72, a PEG ratio of 1.90 and a beta of 0.57. The company’s 50-day moving average price is $48.16 and its two-hundred day moving average price is $47.00.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.68. The company had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The business’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. Research analysts expect that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, August 3rd were issued a dividend of $0.68 per share. The ex-dividend date of this dividend was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. This represents a $2.72 annualized dividend and a yield of 5.8%. Omega Healthcare Investors’s dividend payout ratio is presently 97.14%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on OHI. Citigroup raised their price target on shares of Omega Healthcare Investors from $52.00 to $58.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. BMO Capital Markets reiterated a “market perform” rating and set a $52.00 price objective on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Raymond James Financial assumed coverage on Omega Healthcare Investors in a report on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 price objective for the company. Barclays assumed coverage on Omega Healthcare Investors in a research report on Tuesday, July 7th. They issued an “underweight” rating and a $51.00 target price on the stock. Finally, Truist Financial cut their target price on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a research note on Tuesday, June 9th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus price target of $49.21.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.